Treatment Decision Impact of OncotypeDX™ in HR+, N- Breast Cancer Patients
Intervention Model: Single Group Assignment, Masking: Open Label
impact of the Oncotype DX Recurrence Score on the treatment recommendation made
The impact of Oncotype DX on treatment recommendations can be either a decrease in treatment intensity defined as a change in treatment recommendation from chemotherapy plus hormonal therapy to hormonal therapy alone or an increase in treatment intensity defined as a movement from hormonal therapy alone to the addition of chemotherapy to hormonal therapy.
France: Afssaps - Agence française de sécurité sanitaire des produits de santé (Saint-Denis)